ECP 2019 Final Programme

184 ECP 2019 · Nice Breakfast and Luncheon Industry Symposia 005 14:05–14:25 Multidisciplinary team management in practice: how can effective collaboration deliver high quality and timely patient care? Aleš Ryška, Czech Republic 006 14:25–14:30 Closing remarks Aleš Ryška, Czech Republic LS-13 Industry Symposium 13:00–14:30 Thalie Navigating the complexities of CTCL (Kyowa Kirin) Chair: Rein Willemze, The Netherlands 001 13:00–13:05 Welcome and introduction Rein Willemze, The Netherlands 002 13:05–13:25 Update on the dermatopathology of CTCL: classifying subtypes Rein Willemze, The Netherlands 003 13:25–13:50 Exploring all compartments: molecular and histopathological insights Maxime Battistella, France 004 13:50–14:15 Diagnosing CTCL subtypes: challenges and unmet needs Ilske Oschlies, Germany 005 14:15–14:30 Panel discussion and summary Rein Willemze, The Netherlands Tuesday, 10 Sept LS-11 Industry Symposium 13:00–14:30 Gallieni 5 PD-L1: Debate of experts (Agilent) Chair: Nick Kirk, United Kingdom Experts: Matt Evans, United Kingdom Thorsten Füreder, Austria Søren Nielsen, Denmark Mark Schmid, Switzerland Darlene Krohn, USA LS-15 Industry Symposium 13:00–14:30 Gallieni 4 Optimised treatment decisions for personalised medicine (Biocartis – Genomic Health) Chair: Rick Baehner, USA 001 13:00–13:05 Introduction Caroline Jans, Belgium 002 13:05–13:35 Idylla TM MSI testing in colorectal and endometrial cancer Francisco Javier Matias-Guiu Guia, Spain 003 13:35–14:05 The importance of fast EGFR testing Emmanuel Khalifa, France 004 14:05–14:30 Prediction with precision – guiding chemotherapy treatment in early breast cancer Ulrike Nitz, Germany